Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3DJX

Bovine Seminal Ribonuclease- cytidine 5' phosphate complex

Summary for 3DJX
Entry DOI10.2210/pdb3djx/pdb
Related3DJO 3DJP 3DJQ 3DJV
DescriptorSeminal ribonuclease, CYTIDINE-5'-MONOPHOSPHATE (3 entities in total)
Functional Keywordsribonuclease, hydrolase, allosteric enzyme, endonuclease, nuclease, secreted
Biological sourceBos taurus (Bovine)
Cellular locationSecreted: P00669
Total number of polymer chains2
Total formula weight27911.67
Authors
Dossi, K.,Leonidas, D.D.,Zographos, S.E.,Oikonomakos, N.G. (deposition date: 2008-06-24, release date: 2009-06-30, Last modification date: 2024-11-20)
Primary citationDossi, K.,Tsirkone, V.G.,Hayes, J.M.,Matousek, J.,Pouckova, P.,Soucek, J.,Zadinova, M.,Zographos, S.E.,Leonidas, D.D.
Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors
Eur.J.Med.Chem., 44:4496-4508, 2009
Cited by
PubMed Abstract: Bovine seminal ribonuclease (BS-RNase) is a 27kDa homodimeric enzyme and a member of the pancreatic RNase A superfamily. It is the only RNase with a quaternary structure and it is a mixture of two dimeric forms. In the most abundant form the active site is formed by the swapping of the N-terminal segments. BS-RNase is a potent antitumor agent with severe side effects such as aspermatogenicity, and immunosuppression. As a first step towards the design of potent inhibitors of this enzyme we mapped its active site through the study of the binding of uridine 2'-phosphate (U2'p), uridine 3'-phosphate (U3'p), uridine 5'-diphosphate (UDP), cytidine 3'-phosphate (C3'p), and cytidine 5-phosphate (C5'p), by kinetics, and X-ray crystallography. These phosphonucleotides are potent inhibitors with C3'p being the most potent with a K(i) value of 22 microM. Absorption, distribution, metabolism, and excretion pharmacokinetic property predictions reveal U2'p, U3'p, and C5'p as the most promising with respect to oral bioavailability. In vivo studies on the aspermatogenic effect have shown that C3'p and C5'p inhibit significantly this biological action of BS-RNase.
PubMed: 19643512
DOI: 10.1016/j.ejmech.2009.06.039
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.69 Å)
Structure validation

229380

PDB entries from 2024-12-25

PDB statisticsPDBj update infoContact PDBjnumon